Page 46 - 78_04

CECILIO
GIMÉNEZ

41. Dobbs,
D.
(2010)
Schizophrenia
appears
during
adolescence.
But
where
does
one
begin

and
the
other
end?
Nature
468,
154-­-156.

42. Beneyto,
M.
&
Lewis
DA.
(2011)
Insights
into
the
neurodevelopmental
origin
of

schizophrenia
from
postmortem
studies
of
prefrontal
cortical
circuitry.
International

Journal
of
Developmental
Neuroscience
29,
295-­-304.

43. Sweet,
R.
A.;
Fish,
K.
N.
&
Lewis,
D.
A.
(2010)
Mapping
Synaptic
Pathology
within
Cerebral

Cortical
Circuits
in
Subjects
with
Schizophrenia.
Frontiers
in
Human
Neuroscience
23,
44-­-

52.

44. Volk,
D.
W.
&
Lewis,
D.
A.
(2010)
Prefrontal
cortical
circuits
in
schizophrenia.
Current

Topics
in
Behavioral
Neuroscience
4,
485-­-508.

45. Lewis,
D.
A.
(2011)
The
chandelier
neuron
in
schizophrenia.
Developmental
Neurobiology

71,
118-­-127.

46. Piper,
M.;
Beneyto,
M.;
Burne,
T.
H.;
Eyles,
D.
W.;
Lewis,
D.
A.
&
McGrath,
J.
J.
(2012)
The

neurodevelopmental
hypothesis
of
schizophrenia:
convergent
clues
from
epidemiology

and
neuropathology.
Psychiatric
Clinical
North
America
35,
571-­-584.

47. Lewis,
D.
A.
(2012)
Cortical
circuit
dysfunction
and
cognitive
deficits
in
schizophrenia:

implications
for
preemptive
interventions.
European
Journal
of
Neuroscience
35,
1871-­-
1878.

48. Glausier,
J.R.
&
Lewis,
D.
A.
(2012)
Dendritic
spine
pathology
in
schizophrenia.

Neuroscience.
[Epub
ahead
of
print]
PubMed
PMID:
22546337.

49. Gonzalez-­-Burgos,
G.
&
Lewis,
D.
A.
(2012)
NMDA
Receptor
Hypofunction,
Parvalbumin-­-
Positive
Neurons,
and
Cortical
Gamma
Oscillations
in
Schizophrenia.
Schizophrenia

Bulletin
38,
950-­-957.

50. Stan,
A.
D.
&
Lewis
D.
A.
(2012)
Altered
cortical
GABA
neurotransmission
in

schizophrenia:
Insights
into
novel
therapeutic
strategies.
Current
Pharmological

Biotechnology
13,
1557-­-1562.

51. Curley,
A.
A.
&
Lewis,
D.A.
(2012)
Cortical
basket
cell
dysfunction
in
schizophrenia.

Journal
of
Physiology
590
(Pt
4),
715-­-724.

52. Lewis,
D.
A.;
Curley,
A.
A.;
Glausier,
J.
R.
&
Volk,
D.
W.
(2012)
Cortical
parvalbumin

interneurons
and
cognitive
dysfunction
in
schizophrenia.
Trends
in
Neuroscience
35,
57-­-
67.

53. Volk,
D.
W.;
Eggan,
S.
M.
&
Lewis,
D.A.
(2010)
Alterations
in
metabotropic
glutamate

receptor1a
and
regulator
of
G
protein
signaling
4
in
the
prefrontal
cortex
in

schizophrenia.
American
Journal
of
Psychiatry
167,
1489-­-1498.

54. Gonzalez-­-Burgos,
G.;
Hashimoto,
T.
&
Lewis,
D.
A.
(2010)
Alterations
of
cortical
GABA

neurons
and
network
oscillations
in
schizophrenia.
Current
Psychiatry
Reports
12,
335-­-
344.

55. Lewis,
D.A.
(2009)
Neuroplasticity
of
excitatory
and
inhibitory
cortical
circuits
in

schizophrenia.
Dialogues
on
Clinical
Neuroscience
11,
269-­-80.

56. Bristol,
L.
A.
&
Rothstein,
J.
D.
(1996)
Glutamate
transporter
gene
expression
in

amyotrophic
lateral
sclerosis
motor
cortex.
Annals
of
Neurology
39,
676-­-679.

57. Zafra,
F.
&
Giménez,
C.
(2008)
Glycine
transporters
and
synaptic
function.
IUBMB
Life
60,

810-­-817.

58. Aragón,
C.
&
López-­-Corcuera,
B.
(2005)
Glycine
transporters:
crucial
roles
of

pharmacological
interest
revealed
by
gene
deletion.
Trends
in
Pharmacological
Sciences

26,
283-­-286.

59. Aragón,
C.
&
López-­-Corcuera,
B.
(2003)
Structure,
function
and
regulation
of
glycine

neurotransporters.
European
Journal
of
Pharmacology
31,
249-­-262.

444